Finanzielle Vergleiche Shanghai Shyndec Pharmaceutical Co., Ltd.
Aktien
A0M4PZ
CNE000001JG2
600420
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
11.76 CNY | 0.00% |
|
+0.34% | -1.51% |
22.01. | Die Einheiten von Shyndec Pharma erhalten drei Zulassungszertifikate für Medikamente | MT |
20.01. | Die Shenzhen-Einheit von Shanghai Shyndec besteht EU-GMP-Inspektion | MT |
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | |
---|---|---|---|---|---|---|---|
1.7 Mrd. | 5.73% | - | 6.02% | 3.55% | - | ||
23.2 Mrd. | 13.45% | 17.19% | 14.03% | 7.61% | 1.35x | ||
3.14 Mrd. | 18.36% | 21.67% | 10.2% | 9.89% | -3.42x | ||
829 Mio. | 33.96% | 40.71% | 293.15% | 20.8% | 2.73x | ||
1.43 Mrd. | 7.67% | 3.05% | 6.92% | 5.15% | -0.95x | ||
274 Mio. | 9.56% | 10.45% | 10.96% | 4.74% | 4.35x | ||
346 Mio. | 14.17% | 11% | 6.89% | 4.08% | 2.85x | ||
608 Mio. | 0.22% | 20.59% | - | - | - | ||
207 Mio. | 16.36% | 18.84% | 14.77% | 12.61% | - | ||
257 Mio. | 27.46% | 30.65% | 13.23% | 9.94% | - | ||
1.09 Mrd. | 0.18% | 24.61% | 874.51% | - | -0.27x | ||
500 Mio. | 14.77% | 5.31% | 5.4% | 2.55% | -2.56x | ||
73.86 Mio. | 16.96% | 18.54% | 5.47% | 2.91% | - | ||
592 Mio. | - | 5.52% | 4.85% | 3.16% | - | ||
3.82 Mio. | - | 659.58% | 21.93% | - | 2.36x | ||
646 Mio. | 3.21% | 6.54% | 2.64% | 1.43% | 5.16x | ||
Durchschnitt | 2.18 Mrd. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.16x | |
Gewichteter Durchschnitt nach Marktkapitalisierung | 14.02 Mrd. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.17x |
- Börse
- Aktien
- A0M4PZ Aktie
- Sektor Shanghai Shyndec Pharmaceutical Co., Ltd.
- Finanzielle Vergleiche

MarketScreener is also available in this country: United States.
Switch edition